P B Hylemon - JoVE Visualize

Showing results (111-120 of 113) with videos related to

Pageof 12

Sort By:

You have reached the last page of results.This site can display upto 113 results.

Alimentary Pharmacology & Therapeutics|July 16, 2016

HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patientsJ S Bajaj, R K Sterling, N S Betrapally, et al.

Molecular Biology of the Cell|September 13, 2001

Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosisL Qiao, E Studer, K Leach, et al.

Alimentary Pharmacology & Therapeutics|March 18, 2014

Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosisJ S Bajaj, D M Heuman, P B Hylemon, et al.

Pageof 12

Showing results (111-120 of 113) with videos related to

Sort By:

Pageof 12

You have reached the last page of results.This site can display upto 113 results.

Alimentary Pharmacology & Therapeutics|July 16, 2016

HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patientsJ S Bajaj, R K Sterling, N S Betrapally, et al.

Molecular Biology of the Cell|September 13, 2001

Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosisL Qiao, E Studer, K Leach, et al.

Alimentary Pharmacology & Therapeutics|March 18, 2014

Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosisJ S Bajaj, D M Heuman, P B Hylemon, et al.

Pageof 12